News and Trends 19 Dec 2022Ordaōs and Yatiri Bio to tackle AML Ordaōs has announced a joint development agreement to create new therapeutics for two novel targets in acute myeloid leukemia (AML)… December 19, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email